Inhibitors of Glycogen Synthase Kinase 3 with Exquisite Kinome-Wide Selectivity and Their Functional Effects.
Wagner, F.F., Bishop, J.A., Gale, J.P., Shi, X., Walk, M., Ketterman, J., Patnaik, D., Barker, D., Walpita, D., Campbell, A.J., Nguyen, S., Lewis, M., Ross, L., Weiwer, M., An, W.F., Germain, A.R., Nag, P.P., Metkar, S., Kaya, T., Dandapani, S., Olson, D.E., Barbe, A.L., Lazzaro, F., Sacher, J.R., Cheah, J.H., Fei, D., Perez, J., Munoz, B., Palmer, M., Stegmaier, K., Schreiber, S.L., Scolnick, E., Zhang, Y.L., Haggarty, S.J., Holson, E.B., Pan, J.Q.(2016) ACS Chem Biol 11: 1952-1963
- PubMed: 27128528 
- DOI: 10.1021/acschembio.6b00306
- Primary Citation of Related Structures:  
5HLN, 5HLP - PubMed Abstract: 
The mood stabilizer lithium, the first-line treatment for bipolar disorder, is hypothesized to exert its effects through direct inhibition of glycogen synthase kinase 3 (GSK3) and indirectly by increasing GSK3's inhibitory serine phosphorylation. GSK ...